New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Omega Healthcare Investors, Inc.

OHI

Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.

Revenue
+9.30%
EPS
−54.2%
Free cash flow
n/m
Total debt
−19.5%

Quarter to September 2026, against a year earlier

45.53 0.39 −0.85%

After hours trading: 45.09, down 0.97%, last trade 7:27pm Eastern.

Market cap
$14.0B
P/E
18.2×
Fwd P/E FY26e
19.4×
Dividend yield
5.93%
F-score
6/9
ROIC
4.65%
Net debt / EBITDA
4.0×
Payout ratio
1.1×

Revenue to profit Fiscal 2025, year to Dec 31, 2025

Of every $100 of revenue, $51.21 was left as profit. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue1.2100.0%
Cost of revenue0.00.0%
Gross profit1.2100.0%
Selling, general & admin−0.1−8.8%
Other operating costs−0.4−31.0%
Operating income0.760.3%
Other income, net−0.1−7.8%
Income tax0.0−1.2%
Net income0.651.2%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue$901M$908M$882M$929M$892M$1.1B$878M$950M$1.1B$1.2B
Operating income$560M$315M$473M$496M$381M$520M$312M$392M$624M$717M
Net income$383M$105M$294M$352M$164M$428M$439M$249M$418M$609M
Net margin (right axis)42.6%11.5%33.3%37.9%18.3%40.3%50.0%26.2%39.7%51.2%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
900.83 908.39 881.68 928.83 892.38 1,062.81 878.24 949.74 1,051.39 1,190.10
Revenue Growth
21.14% 0.84% (2.94%) 5.35% (3.92%) 19.10% (17.37%) 8.14% 10.70% 13.19%
Gross Profit
900.83 908.39 881.68 928.83 892.38 1,062.81 878.24 949.74 1,051.39 1,190.10
Operating Income
559.95 315.17 472.82 496.05 380.82 520.42 311.82 391.69 624.22 717.11
EBT
384.33 105.92 296.51 343.84 162.33 416.08 436.14 255.63 420.75 624.43
Income after Tax
382.93 102.67 293.50 341.00 157.40 412.24 431.58 249.38 409.89 609.69
Net Income Common
366.42 100.42 281.58 341.12 159.33 416.74 438.84 249.26 418.39 591.39
EPS (Diluted)
1.90 0.51 1.40 1.58 0.70 1.75 1.80 1.00 1.55 1.94
Shares (Diluted, Weighted)
201.64 206.79 209.71 222.13 235.10 244.34 244.29 250.45 270.45 304.95
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBIT Margin
62.16% 34.70% 53.63% 53.41% 42.67% 48.97% 35.50% 41.24% 59.37% 60.26%
Net Profit Margin
40.68% 11.05% 31.94% 36.73% 17.85% 39.21% 49.97% 26.24% 39.79% 49.69%
Free Cash Flow Margin
(49.34%) 11.65% 25.52% (1.79%) 55.63% (3.18%) 37.73% 28.72% 22.26% 6.81%
EBITDA
824.48 610.57 752.35 801.39 708.17 895.97 651.90 725.56 941.01 1,043.33
EBIT
559.95 315.17 472.82 496.05 380.82 520.42 311.82 391.69 624.22 717.11

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026